Winan van Houdt, MD, PhD

Surgical Oncologist
Netherlands Cancer Institute
Amsterdam, Noord-Holland, Netherlands

Disclosure information not submitted.

Presentation(s):

• Paper 37 - CINSARC IN PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA: COMBINED ANALYSIS OF EORTC-STBSG-62092 TRIAL (STRASS) AND SINGLE INSTITUTION DATA

  Friday, November 15, 2024
  8:00 AM – 9:00 AM PST

• Paper 38 - DEFINING NOVEL BENCHMARK VALUES FOR OUTCOMES OF COMPREHENSIVE RESECTION OF PRIMARY RETROPERITONEAL LIPOSARCOMA

  Friday, November 15, 2024
  8:00 AM – 9:00 AM PST

• Paper 39 - HISTOLOGIC ORGAN INFILTRATION AND RELATION WITH SURGEON PREOPERATIVE ASSESSMENT IN RETROPERITONEAL SARCOMA. A STUDY FROM TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)

  Friday, November 15, 2024
  8:00 AM – 9:00 AM PST

• Sarcoma of the Year: Dedifferentiated Liposarcoma

  Friday, November 15, 2024
  9:00 AM – 10:00 AM PST

• Paper 51 - PANDEMIC DRIVEN PREOPERATIVE HYPOFRACTIONATED RADIOTHERAPY FOR SOFT TISSUE SARCOMAS

  Friday, November 15, 2024
  11:15 AM – 12:45 PM PST